LYN and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, LYN overexpression has been reported in several cancers, such as chronic myelogenous leukemia [26], colorectal cancer [27], breast cancer [28], prostate cancer [29], oral cancer [30], renal cancer [31] and Ewing’s sarcoma [32]; nonetheless, no previous study has evaluated the role of LYN in gastric carcinogenesis.